Skip to content

Energy Ramping Versus Fixed Dose ESWL

Energy Ramping Versus Fixed Dose ESWL on Stone-Free Rate (Comparative Study)

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07334236
Enrollment
100
Registered
2026-01-12
Start date
2026-01-03
Completion date
2026-11-01
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Calculi

Brief summary

This clinical trial compares two techniques of extracorporeal shock wave lithotripsy (ESWL) - energy ramping versus fixed dose - in adult patients with renal stones. The study aims to evaluate stone-free rates, retreatment needs, and safety outcomes across multiple clinical sites in Egypt.

Detailed description

This multi-center, randomized controlled trial investigates the impact of energy ramping versus fixed-dose ESWL on stone clearance in patients with solitary renal calculi. Participants will be assigned to either a gradually increasing energy protocol or a constant energy protocol using standardized lithotripter settings. The primary outcome is stone-free rate at two weeks post-treatment, assessed via imaging. Secondary outcomes include retreatment rate, pain scores, adverse events, and procedure duration. The study is conducted under IRB approval from Sohag University and follows international ethical standards for human research.

Interventions

Fixed Voltage (experimental): Subjects receive shock wave therapy at a constant energy level (e.g., 20-22 kV) for the entire duration of the session. Standard delivery includes approximately 3,000 shocks at a frequency of 60-90 shocks per minute. Voltage Ramping (control): Subjects receive shock wave therapy starting at a low energy level (e.g., 6-10 kV) for an initial priming phase of 100-500 shocks. Energy is then escalated in predefined increments (e.g., 1-2 kV every 250-500 shocks) until reaching the target therapeutic voltage.

Sponsors

mohammed Abdelhafez
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Randomized Parallel Assignment Randomized, two-arm parallel assignment comparing energy-ramping ESWL versus fixed-dose ESWL; participants randomized 1:1. Treatment allocation is stratified by stone size (\<10 mm vs ≥10 mm). Primary outcomes assessed at 3 months post-treatment.

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults ≥18 years. * Radiopaque renal or proximal/mid ureteral stone ≤20 mm. * eGFR ≥60 mL/min/1.73 m². * Fit for ESWL. * Able to give informed consent and complete follow up.

Exclusion criteria

* • Pregnancy. * Active, untreated UTI. * Uncorrected bleeding disorder or anticoagulation that cannot be stopped. * Prior ipsilateral renal surgery. * Non radio-opaque stone without reliable imaging. * Inability to tolerate ESWL or required anesthesia.

Design outcomes

Primary

MeasureTime frameDescription
Stone free rate4 weeksProportion of participants achieving complete stone clearance as confirmed by imaging (ultrasound or CT).

Secondary

MeasureTime frame
Number of ESWL sessions to achieve SFR.4 weeks

Countries

Egypt

Contacts

Primary Contactmohammed A Abdelhafez
3elwa97@gmail.com+201143548707

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026